CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.83
+0.08 (0.74%)
Jul 31, 2025, 11:00 AM GMT+1

CRISM Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
441142422
Upgrade
Market Cap Growth
14.70%186.75%-91.00%-40.80%6.56%31.56%
Upgrade
Enterprise Value
32-5102221
Upgrade
Last Close Price
0.110.110.140.030.060.06
Upgrade
PS Ratio
171.84143.7827.86---
Upgrade
PB Ratio
2.912.44-2.090.601.060.96
Upgrade
P/TBV Ratio
3.072.57-0.601.063.86
Upgrade
EV/Sales Ratio
120.5669.30----
Upgrade
Debt / Equity Ratio
---1.16---
Upgrade
Asset Turnover
0.030.030.00---
Upgrade
Quick Ratio
3.913.910.033.786.033.06
Upgrade
Current Ratio
4.964.960.0331.2127.723.46
Upgrade
Return on Equity (ROE)
-135.70%-135.70%-1.85%-8.99%-5.83%-9.12%
Upgrade
Return on Assets (ROA)
-56.61%-56.61%-0.94%-4.63%-3.51%-6.36%
Upgrade
Return on Capital (ROIC)
-70.02%-70.02%-0.97%-4.80%-3.64%-6.60%
Upgrade
Earnings Yield
-14.13%-16.89%-15.63%-17.95%-3.79%-8.85%
Upgrade
FCF Yield
--25.96%-7.82%-20.94%-7.09%-9.16%
Upgrade
Buyback Yield / Dilution
-269.83%-201033.86%99.82%-0.85%-28.82%-45.57%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.